reference/2364930

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2364930

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural
endingPage	3882
issn	1078-0432 1557-3265
issueIdentifier	13
pageRange	3875-3882
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	3875
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_58697f11dbb92a834ead43cc17e973d9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fe6263cad1815a6b6fc10ab949829c6b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_93b4ade58871337c8f9b03ecce791ec3 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_29de4e98b125abcdee42b645dd37d323
bibliographicCitation	Kim JH, Bogner PN, Ramnath N, Park Y, Yu J, Park YM. Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer. Clin Cancer Res. 2007 Jul 01;13(13):3875–82. doi: 10.1158/1078-0432.ccr-06-2893. PMID: 17606720.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24e1205c87a96f4c44606d2f4c0b4f55 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9da5939bc8f120fcd632ba861fac8c0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d2b706a0cf37e726887e076bde0aff90 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f6eb0d0b00996ac7a7aafd57e0eca0c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63677dad710644299a91e08f80ef0824 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0fc18ac1fd19da3dcb3acecc9b987d7
date	2007-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/17606720 https://doi.org/10.1158/1078-0432.ccr-06-2893
isPartOf	https://portal.issn.org/resource/ISSN/1078-0432 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1557-3265
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Elevated Peroxiredoxin 1, but not NF-E2–Related Factor 2, Is an Independent Prognostic Factor for Disease Recurrence and Reduced Survival in Stage I Non–Small Cell Lung Cancer
discusses	http://id.nlm.nih.gov/mesh/M0237441 http://id.nlm.nih.gov/mesh/M0231262 http://id.nlm.nih.gov/mesh/M0352091 http://id.nlm.nih.gov/mesh/M0016376
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008175Q000378 http://id.nlm.nih.gov/mesh/D002289Q000235 http://id.nlm.nih.gov/mesh/D010544Q000096 http://id.nlm.nih.gov/mesh/D051267Q000096 http://id.nlm.nih.gov/mesh/D015972
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008175Q000401 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D002289Q000401 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D054464 http://id.nlm.nih.gov/mesh/D012008 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D012044 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008175Q000473
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_70c5c45421e877b3b4dc7a69ea4df9bd http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f56a221bc770a5fa884ac7d3634f29a8 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68245 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5052 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4780

Total number of triples: 62.